IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Matrix Capital Management Company, LP

Q4 2025 Holdings

Filed 2026-02-13 | 2 holdings | $57.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aura Biosciences Inc(AURA)COM05153U107$37.7M6,922,87065.5%
Maze Therapeutics Inc(MAZE)COM578784100$19.9M480,00034.5%